Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760160 · ClinicalTrials.gov registry record · NA
Dietary Prevention of Photodamage in Skin With Grapes
A NA study of Non-Melanoma Skin Cancer, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02760160 is a NA study of Non-Melanoma Skin Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 18 participants, below the 55-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02760160, a NA study of Non-Melanoma Skin Cancer, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the effect of orally administered grape powder on the sunburn reaction in humans.
Conditions Studied
Interventions
- OTHER Reconstituted grape powder
Study Locations (1)
Alabama
- UAB Dermatology - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02760160
The ClinicalTrials.gov registry entry for NCT02760160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (67% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Reconstituted grape powder is the first listed.
NCT02760160 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02760160 about?
NCT02760160 is a clinical study titled "Dietary Prevention of Photodamage in Skin With Grapes". To assess the effect of orally administered grape powder on the sunburn reaction in humans.
What is the current status of trial NCT02760160?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-10. Estimated completion is 2018-09-27.
What conditions does trial NCT02760160 study?
This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.
What interventions are being tested in trial NCT02760160?
The interventions under investigation include: Reconstituted grape powder (OTHER).
Who is sponsoring clinical trial NCT02760160?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02760160 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Melanoma Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
COMPLETED
-
Preoperative Acetaminophen and Carbohydrate Loading
COMPLETED · Phase 3
-
Can We Miss Pigmented Lesions in Psoriasis Patients?
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.